OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease-Reference-Cited by-同舟云学术

OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease

Published:2020-07-22 Issue:7 Volume:15 Page:e0236447
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tran Huong T. L.,Morikawa Kenichi,Anggakusuma ,Zibi Rose,Thi Viet Loan Dao,Penin François^ORCID,Heim Markus H.,Quadroni Manfredo,Pietschmann Thomas,Gouttenoire Jérôme^ORCID,Moradpour Darius

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Novartis Stiftung für Medizinisch-Biologische Forschung

FP7 Ideas: European Research Council

Helmholtz-Gemeinschaft

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Global elimination of chronic hepatitis;DL Thomas;N Engl J Med,2019

2. Future landscape of hepatitis C research: basic, translational and clinical perspectives;D Moradpour;J Hepatol,2016

3. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies;R Bartenschlager;Virus Res,2018

4. Replication of hepatitis C virus;D Moradpour;Nat Rev Microbiol,2007

5. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus;K Morikawa;J Viral Hepat,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation;PLOS Pathogens;2023-08-16

2. Antiviral PROTACs: Opportunity borne with challenge;Cell Insight;2023-06

3. Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations;Journal of Computer-Aided Molecular Design;2022-11-25

4. Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations;2022-08-26

5. Recent advancement in small molecules as HCV inhibitors;Bioorganic & Medicinal Chemistry;2022-04